t’s a discovery that is not going down well with the Indian healthcare system.  A report in medical journal Lancet on the discovery of a new superbug in India has sparked off a war of words between the medical community in the UK and that in India. The quarrel, of course, is over the quality of healthcare in the country. The Indian healthcare industry fears the hype about the new drug-resistant bacteria will hit “medical tourism”. The greater concern, however, is the potential threat the bug poses to patients in our country and the growing problem of drug-resistant strains in India.

Read more: